Saccharin induced liver inflammation in mice by altering the gut microbiota and its metabolic functions

Food and Chemical Toxicology

Volumn 107, Issue , 2017, Pages 530-539

  Bian, Xiaoming ^a   Tu, Pengcheng ^b   Chi, Liang ^b   Gao, Bei ^a   Ru, Hongyu ^c   Lu, Kun ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Artificial sweetener; Gut microbiota; Inflammation; Metabolite; Saccharin

Indexed keywords

BACTERIAL TOXIN; DRINKING WATER; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; PATHOGEN ASSOCIATED MOLECULAR PATTERN; RNA 16S; SACCHARIN; TUMOR NECROSIS FACTOR; SWEETENING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; HEPATITIS; INTESTINE FLORA; MALE; METABOLISM; METABOLOMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA GENE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENETICS; HUMAN; IMMUNOLOGY; LIVER; LIVER DISEASES; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; SACCHARIN; SWEETENING AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85019183040     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2017.04.045     Document Type: Article

References (61)

1. Aktan, F., iNOS-mediated nitric oxide production and its regulation. Life Sci. 75:6 (2004), 639–653, 10.1016/j.lfs.2003.10.042.
2. Alkhouri, N., Gornicka, A., Berk, M.P., Thapaliya, S., Dixon, L.J., Kashyap, S., Feldstein, A.E., Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J. Biol. Chem. 285:5 (2010), 3428–3438, 10.1074/jbc.M109.074252.
3. Asshauer, K.P., Wemheuer, B., Daniel, R., Meinicke, P., Tax4Fun: predicting functional profiles from metagenomic 16S rRNA data. Bioinformatics 31:17 (2015), 2882–2884, 10.1093/bioinformatics/btv287.
4. Atkinson, C., Frankenfeld, Cara L., Lampe, J.W., Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. 230:3 (2005), 155–170.
5. Bajaj, J.S., Hylemon, P.B., Ridlon, J.M., Heuman, D.M., Daita, K., White, M.B., Gillevet, P.M., Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 303:6 (2012), G675–G685, 10.1152/ajpgi.00152.2012.
6. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Knight, R., QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7:5 (2010), 335–336, 10.1038/nmeth.f.303.
7. Chamulitrat, W., Jordan, Sandra J., Mason, Ronald P., Litton, Amy L., Wilson, Joan G., Wood, Edgar R., Vedia, L.M.Y., Targets of nitric oxide in a mouse model of liver inflammation by Corynebacterium parvum. Archives Biochem. biophysics 316:1 (1995), 30–37.
8. Collins, J.W., Chervaux, C., Raymond, B., Derrien, M., Brazeilles, R., Kosta, A., Frankel, G., Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia. J. Infect. Dis. 210:7 (2014), 1029–1041, 10.1093/infdis/jiu205.
9. Coussens, L.M., Werb, Z., Inflammation and cancer. Nature 420:6917 (2002), 860–867.
10. Cullender, T.C., Chassaing, B., Janzon, A., Kumar, K., Muller, C.E., Werner, J.J., Ley, R.E., Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe 14:5 (2013), 571–581, 10.1016/j.chom.2013.10.009.
11. de La Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C., Raybould, H.E., Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 299:2 (2010), G440–G448, 10.1152/ajpgi.00098.2010.
12. Decroos, K., Vanhemmens, S., Cattoir, S., Boon, N., Verstraete, W., Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch. Microbiol. 183:1 (2005), 45–55, 10.1007/s00203-004-0747-4.
13. Ezzili, C., Otrubova, K., Boger, D.L., Fatty acid amide signaling molecules. Bioorg Med. Chem. Lett. 20:20 (2010), 5959–5968, 10.1016/j.bmcl.2010.08.048.
14. Fernández, J., Redondo-Blanco, S., Gutiérrez-del-Río, I., Miguélez, E.M., Villar, C.J., Lombó, F., Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: a review. J. Funct. Foods 25 (2016), 511–522, 10.1016/j.jff.2016.06.032.
15. Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L., Clement, K., Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59:12 (2010), 3049–3057, 10.2337/db10-0253.
16. Garcia-Ruiz, I., Rodriguez-Juan, C., Diaz-Sanjuan, T., del Hoyo, P., Colina, F., Munoz-Yague, T., Solis-Herruzo, J.A., Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44:3 (2006), 581–591, 10.1002/hep.21313.
17. Gou, Z., Jiang, S., Zheng, C., Tian, Z., Lin, X., Equol inhibits LPS-induced oxidative stress and enhances the immune response in chicken HD11 macrophages. Cell Physiol. Biochem. 36:2 (2015), 611–621, 10.1159/000430124.
18. Grivennikov, S.I., Wang, K., Mucida, D., Stewart, C.A., Schnabl, B., Jauch, D., Karin, M., Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491:7423 (2012), 254–258, 10.1038/nature11465.
19. Holmes, E., Li, J.V., Athanasiou, T., Ashrafian, H., Nicholson, J.K., Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 19:7 (2011), 349–359, 10.1016/j.tim.2011.05.006.
20. Hwang, J., Wang, J., Morazzoni, P., Hodis, H.N., Sevanian, A., The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic. Biol. Med. 34:10 (2003), 1271–1282, 10.1016/s0891-5849(03)00104-7.
21. Ishida, T., Nishiumi, S., Tanahashi, T., Yamasaki, A., Yamazaki, A., Akashi, T., Mizuno, S., Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice. Eur. J. Pharmacol. 699:1–3 (2013), 6–13, 10.1016/j.ejphar.2012.11.030.
22. Jonsson, A.L., Backhed, F., Drug the bug!. Cell 163:7 (2015), 1565–1566, 10.1016/j.cell.2015.12.005.
23. Kau, A.L., Ahern, P.P., Griffin, N.W., Goodman, A.L., Gordon, J.I., Human nutrition, the gut microbiome and the immune system. Nature 474:7351 (2011), 327–336, 10.1038/nature10213.
24. Keszthelyi, D., Troost, F.J., Masclee, A.A., Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol. Motil. 21:12 (2009), 1239–1249, 10.1111/j.1365-2982.2009.01370.x.
25. Kinross, J.M., Roon, A. C. v., Holmes, E., Darzi, A., Nicholson, J.K., The human gut microbiome: implications for future health care. Curr. Gastroenterol. Rep. 10:4 (2008), 396–403.
26. La Mura, V., Pasarin, M., Rodriguez-Vilarrupla, A., Garcia-Pagan, J.C., Bosch, J., Abraldes, J.G., Liver sinusoidal endothelial dysfunction after LPS administration: a role for inducible-nitric oxide synthase. J. Hepatol. 61:6 (2014), 1321–1327, 10.1016/j.jhep.2014.07.014.
27. Lawrie, C.A., Renwick, A.G., Sims, J., The urinary excretion of bacterial amino-acid metabolites by rats fed saccharin in the diet. Food Chem. Toxicol. 23:4–5 (1985), 445–450.
28. Libby, P., Ridker, P.M., Maseri, A., Inflammation and atherosclerosis. Circulation 105:9 (2002), 1135–1143, 10.1161/hc0902.104353.
29. Lin, I.C., Yamashita, S., Murata, M., Kumazoe, M., Tachibana, H., Equol suppresses inflammatory response and bone erosion due to rheumatoid arthritis in mice. J. Nutr. Biochem. 32 (2016), 101–106, 10.1016/j.jnutbio.2016.02.012.
30. Lu, K., Abo, R.P., Schlieper, K.A., Graffam, M.E., Levine, S., Wishnok, J.S., Fox, J.G., Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ. Health Perspect. 122:3 (2014), 284–291, 10.1289/ehp.1307429.
31. Lu, K., Knutson, C.G., Wishnok, J.S., Fox, J.G., Tannenbaum, S.R., Serum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism. J. Proteome Res. 11:10 (2012), 4916–4926, 10.1021/pr300429x.
32. Madianos, P.N., Bobetsis, Y.A., Kinane, D.F., Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J. Clin. periodontology 32:6 (2005), 57–71.
33. Mallett, A.K., Rowland, I.R., Bearne, C.A., Modification of rat caecal microbial biotransformation activities by dietary saccharin. Toxicology 36:2–3 (1985), 253–262.
34. Marshall, B.M., Ochieng, Dorothy J., Levy, S.B., Commensals: underappreciated reservoir of antibiotic resistance. Microbe 4:5 (2009), 231–238.
35. Maruo, T., Sakamoto, M., Ito, C., Toda, T., Benno, Y., Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int. J. Syst. Evol. Microbiol. 58:Pt 5 (2008), 1221–1227, 10.1099/ijs.0.65404-0.
36. Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., Mackay, C.R., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:7268 (2009), 1282–1286, 10.1038/nature08530.
37. Nakagawa, I., Functional differences among FimA variants of Porphyromonas gingivalis and their effects on adhesion to and invasion of human epithelial cells. Infect. Immun. 70:1 (2002), 277–285, 10.1128/iai.70.1.277-285.2002.
38. Ng, S.C., Lam, E.F., Lam, T.T., Chan, Y., Law, W., Tse, P.C., Wu, J.C., Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J. Gastroenterol. Hepatol. 28:10 (2013), 1624–1631, 10.1111/jgh.12306.
39. Nishiuma, T., Nishimura, Y., Okada, T., Kuramoto, E., Kotani, Y., Jahangeer, S., Nakamura, S., Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am. J. Physiol. Lung Cell Mol. Physiol. 294:6 (2008), L1085–L1093, 10.1152/ajplung.00445.2007.
40. Parks, D.H., Tyson, G.W., Hugenholtz, P., Beiko, R.G., STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30:21 (2014), 3123–3124, 10.1093/bioinformatics/btu494.
41. Parlee, S.D., Simon, B.R., Scheller, E.L., Alejandro, E.U., Learman, B.S., Krishnan, V., MacDougald, O.A., Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females. Endocrinology 155:4 (2014), 1313–1326, 10.1210/en.2013-1995.
42. Piddock, L.J., Multidrug-resistance efflux pumps? not just for resistance. Nat. Rev. Microbiol. 4:8 (2006), 629–636.
43. Renwick, A.G., The disposition of saccharin in animals and man—a review. Food Chem. Toxicol. 23:4–5 (1985), 429–435.
44. Sass, G., Koerber, K., Bang, R., Guehring, H., Tiegs, G., Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest 107:4 (2001), 439–447, 10.1172/JCI10613.
45. Shankar, P., Ahuja, S., Sriram, K., Non-nutritive sweeteners: review and update. Nutrition 29:11–12 (2013), 1293–1299, 10.1016/j.nut.2013.03.024.
46. Song, J.M., Qian, X., Molla, K., Teferi, F., Upadhyaya, P., OSullivan, G., Luo, X., Kassie, F., Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators. Carcinogenesis 36:6 (2015), 666–675, 10.1093/carcin/bgv054.
47. Spencer, M., Gupta, A., Dam, L.V., Shannon, C., Menees, S., Chey, W.D., Artificial sweeteners: a systematic review and primer for gastroenterologists. J. Neurogastroenterol. Motil. 22:2 (2016), 168–180, 10.5056/jnm15206.
48. Subedi, L., Ji, E., Shin, D., Jin, J., Yeo, J.H., Kim, S.Y., Equol, a dietary daidzein gut metabolite attenuates microglial activation and potentiates neuroprotection in vitro. Nutrients, 9(3), 2017, 10.3390/nu9030207.
49. Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C.A., Maza, O., Elinav, E., Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514:7521 (2014), 181–186, 10.1038/nature13793.
50. Swithers, S.E., Martin, A.A., Clark, K.M., Laboy, A.F., Davidson, T.L., Body weight gain in rats consuming sweetened liquids. Effects of caffeine and diet composition. Appetite 55:3 (2010), 528–533, 10.1016/j.appet.2010.08.021.
51. Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489:7415 (2012), 242–249, 10.1038/nature11552.
52. Turnbaugh, P.J., Gordon, J.I., The core gut microbiome, energy balance and obesity. J. Physiol. 587:Pt 17 (2009), 4153–4158.
53. Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R., Gordon, J.I., The human microbiome project. Nature 449:7164 (2007), 804–810, 10.1038/nature06244.
54. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1031, 10.1038/nature05414.
55. Uronis, J.M., Muhlbauer, M., Herfarth, H.H., Rubinas, T.C., Jones, G.S., Jobin, C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One, 4(6), 2009, e6026, 10.1371/journal.pone.0006026.
56. Wang, L., Zhang, Z.G., Zhang, R.L., Gregg, S.R., Hozeska-Solgot, A., LeTourneau, Y., Chopp, M., Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J. Neurosci. 26:22 (2006), 5996–6003, 10.1523/JNEUROSCI.5380-05.2006.
57. White, J.R., Nagarajan, N., Pop, M., Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput. Biol., 5(4), 2009, e1000352, 10.1371/journal.pcbi.1000352.
58. Wu, Y., Zhou, B.P., TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer 102:4 (2010), 639–644, 10.1038/sj.bjc.6605530.
59. Xavier, R.J., Podolsky, D.K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:7152 (2007), 427–434, 10.1038/nature06005.
60. Xu, L., Peng, H., Wu, D., Hu, K., Goldring, M.B., Olsen, B.R., Li, Y., Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J. Biol. Chem. 280:1 (2005), 548–555, 10.1074/jbc.M411036200.
61. Zhang, L., Nichols, R.G., Correll, J., Murray, I.A., Tanaka, N., Smith, P.B., Patterson, A.D., Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation. Environ. Health Perspect. 123:7 (2015), 679–688, 10.1289/ehp.1409055.